A slew of publicly traded firms along the vaccine supply chain are set to cash in as widespread inoculation kicks into high gear in the coming weeks; here are some of the firms set to profit the most from vaccine-making and distribution, according to a Bank of America note sent to clients on Wednesday.... [+]Key Facts
Meanwhile, Pennsylvania-based West Pharmaceutical, the maker of rubber stoppers used for vaccine packaging, should lead gains in its industry, analysts forecast, with a more than 15% increase in profit, which last year totaled $242 million. In the United States, FedEx and UPS are estimated to see domestic revenues rise between $100 million to $300 million apiece for their vaccine distribution efforts, but that's a pittance relative to overall annual revenues of roughly $20 billion each.